We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSTR icon
2051
Strategy Inc
MSTR
$38.4B
$3.68M ﹤0.01%
259,700
-27,640
-10% -$565K
RUTH
2052
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$3.67M ﹤0.01%
237,147
-137,788
-37% -$2.42M
CHRS icon
2053
Coherus Oncology
CHRS
$196M
$3.66M ﹤0.01%
462,526
-266,911
-37% -$2.05M
VSTO
2054
DELISTED
Vista Outdoor Inc.
VSTO
$3.66M ﹤0.01%
150,169
-46,741
-24% -$1.23M
HAFC icon
2055
Hanmi Financial
HAFC
$946M
$3.66M ﹤0.01%
147,735
-26,162
-15% -$666K
CMCO icon
2056
Columbus McKinnon
CMCO
$584M
$3.65M ﹤0.01%
112,336
-138,700
-55% -$4.1M
VERV
2057
DELISTED
Verve Therapeutics
VERV
$3.65M ﹤0.01%
188,474
-109,910
-37% -$2.91M
EVBG
2058
DELISTED
Everbridge, Inc. Common Stock
EVBG
$3.65M ﹤0.01%
123,299
+10,808
+10% +$331K
FBRT
2059
Franklin BSP Realty Trust
FBRT
$657M
$3.64M ﹤0.01%
282,417
+5,907
+2% +$79K
NMRK icon
2060
Newmark Group
NMRK
$2.63B
$3.63M ﹤0.01%
455,717
-311,316
-41% -$2.6M
MYGN icon
2061
Myriad Genetics
MYGN
$312M
$3.62M ﹤0.01%
249,364
-37,016
-13% -$690K
MTW icon
2062
Manitowoc
MTW
$675M
$3.61M ﹤0.01%
394,606
+193,930
+97% +$1.77M
PEGA icon
2063
Pegasystems
PEGA
$5.38B
$3.61M ﹤0.01%
210,912
-50
-0% -$865
ASPN icon
2064
Aspen Aerogels
ASPN
$518M
$3.61M ﹤0.01%
306,078
-153,193
-33% -$1.75M
GTES icon
2065
Gates Industrial Corporation Ltd.
GTES
$7.15B
$3.61M ﹤0.01%
316,090
+89,583
+40% +$988K
ATHM icon
2066
Autohome
ATHM
$2.62B
$3.6M ﹤0.01%
117,723
-500
-0.4% -$14.9K
NNI icon
2067
Nelnet
NNI
$4.7B
$3.6M ﹤0.01%
39,698
-6,943
-15% -$630K
CLW icon
2068
Clearwater Paper
CLW
$376M
$3.59M ﹤0.01%
94,949
+10,048
+12% +$392K
VREX icon
2069
Varex Imaging
VREX
$523M
$3.56M ﹤0.01%
175,392
-8,602
-5% -$180K
AEM icon
2070
Agnico Eagle Mines
AEM
$90.5B
$3.55M ﹤0.01%
26,119
-1,055
-4% -$49.8K
ZEUS
2071
DELISTED
Olympic Steel
ZEUS
$3.54M ﹤0.01%
105,490
-5,943
-5% -$179K
IHRT icon
2072
iHeartMedia
IHRT
$583M
$3.54M ﹤0.01%
577,339
-59,995
-9% -$462K
LBRDA icon
2073
Liberty Broadband Class A
LBRDA
$5.16B
$3.53M ﹤0.01%
46,550
-14,235
-23% -$1.16M
UFPT icon
2074
UFP Technologies
UFPT
$2.43B
$3.53M ﹤0.01%
29,936
+4,792
+19% +$511K
SPHR icon
2075
Sphere Entertainment
SPHR
$5.73B
$3.53M ﹤0.01%
78,459
-11,425
-13% -$518K

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.